BTTR BETTER CHOICE CO INC

SRx Health Solutions Appoints Sammy Dorf to Board of Directors

SRx Health Solutions Appoints Sammy Dorf to Board of Directors

TAMPA, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”) today announced the appointment of Sammy Dorf, Esq. to its Board of Directors.

Sammy is a pioneering force in the modern cannabis economy and one of the industry’s most accomplished dealmakers, strategists, and growth architects. Most recently serving as Executive Chairman of Flora Growth Corp. (NASDAQ: FLGC), Sammy guided the company through a transformative phase marked by innovation, disciplined expansion, and a strategic transition into a crypto treasury company.

With nearly a decade of leadership at the intersection of cannabis, capital markets, and strategic development, Sammy brings an unmatched combination of legal expertise, entrepreneurial insight, and operational execution. His career has been defined by his ability to envision and deliver large-scale growth initiatives that balance community engagement, regulatory excellence, and brand innovation.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. The Company has based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Some or all of the results anticipated by these forward-looking statements may not be achieved. Further information on the Company’s risk factors is contained in our filings with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

Company Contact:

SRx Health Solutions, Inc.

Kent Cunningham, Chief Executive Officer

Investor Contact:

KCSA Strategic Communications

Valter Pinto, Managing Director

T: 212-896-1254



EN
10/11/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on BETTER CHOICE CO INC

 PRESS RELEASE

SRx Health Solutions Appoints Sammy Dorf to Board of Directors

SRx Health Solutions Appoints Sammy Dorf to Board of Directors TAMPA, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”) today announced the appointment of Sammy Dorf, Esq. to its Board of Directors. Sammy is a pioneering force in the modern cannabis economy and one of the industry’s most accomplished dealmakers, strategists, and growth architects. Most recently serving as Executive Chairman of Flora Growth Corp. (NASDAQ: FLGC), Sammy guided the company through a transformative phase marked by innovation, disciplined expansion, and ...

 PRESS RELEASE

SRx Health Solutions Provides Response Related to Unusual Market Tradi...

SRx Health Solutions Provides Response Related to Unusual Market Trading Activity Received by the NYSE American Exchange TAMPA, Fla., Nov. 06, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”) today announced the Company has been notified by the NYSE American of unusual trading activity of its Common Shares on November 6, 2025. The Company is not aware of any material developments in its business or affairs beyond those that have been publicly disclosed. Investors should rely solely on the Company’s filings with the SEC and its press releases. The ...

 PRESS RELEASE

SRx Health Solutions Received NYSE American Notification Letter Regard...

SRx Health Solutions Received NYSE American Notification Letter Regarding Stockholders' Equity Deficiency TAMPA, Fla., Oct. 17, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”) today announced it received a notice from the staff of NYSE American LLC (the “Exchange”) that the Company was not in compliance with the Exchange’s continued listing standards under Section 1003(a)(ii) of the NYSE American Company Guide. Section 1003(a)(ii) requires a listed company to have stockholders’ equity of $4 million or more if the listed company has reported losse...

 PRESS RELEASE

SRx Health Solutions Appoints Joshua Epstein to Board of Directors and...

SRx Health Solutions Appoints Joshua Epstein to Board of Directors and Compensation Committee TAMPA, Fla., Oct. 01, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”) today announced the appointment of Joshua Epstein to the Board of Directors and Compensation Committee. Forward Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “...

 PRESS RELEASE

SRx Health Solutions Cancels an Additional 350,000 Shares, Increasing ...

SRx Health Solutions Cancels an Additional 350,000 Shares, Increasing the Total Number of Shares Canceled to Over 19 Million All legal options remain under consideration regarding the actions of former SRx Canada officers TAMPA, Fla., Aug. 29, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”), a leading global health and wellness company, today announced the cancellation of an additional 350,000 shares, increasing the total number of shares canceled to over 19 million shares of its capital stock. The cancellation was executed under a Settlement, S...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch